Projects per year
Fingerprint Dive into the research topics where Namur Thrombosis and Hemostasis Center is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Anticoagulants
Medicine & Life Sciences
Thrombin
Medicine & Life Sciences
Hemorrhage
Medicine & Life Sciences
Thrombosis
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Prothrombin Time
Medicine & Life Sciences
Paroxysmal Hemoglobinuria
Medicine & Life Sciences
Coagulation
Chemical Compounds
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Profiles
Lütfiye Alpan
- Department of Pharmacy
- Namur Nanosafety Center
- Namur Research Institute for Life Sciences
- Namur Thrombosis and Hemostasis Center
- NAmur MEdicine & Drug Innovation Center
Person: Volunteer staff, ATO Staff, Definitive ATO Staff
Projects 2006 2020
The HIC Project - evaluation of hormone-induced coagulopathy
Dogne, J., Douxfils, J. & Morimont, L.
1/09/19 → …
Project: PHD
Design, synthesis and evaluation of FXIIa inhibitors: toward chiral peptidomimetic amidines and guanidines
Simon, F., Lanners, S. & Pochet, L.
1/10/18 → 30/09/20
Project: Research
Development of new compounds targeting coagulation factor XIIa using innovative microfluidic assays in the context of fragment-based drug discovery
Davoine, C., Pochet, L. & Fillet, M.
1/10/18 → 30/09/20
Project: Research
Research Output 1989 2019
Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine-A Multicenter Trial
Harenberg, J., Beyer-Westendorf, J., Crowther, M., Douxfils, J., Elalamy, I., Verhamme, P., Bauersachs, R., Hetjens, S. & Weiss, C., 2019, In : Thrombosis and Haemostasis. 9 p.Research output: Contribution to journal › Article
Open Access
File
Factor Xa
Routine Diagnostic Tests
Thrombin
Anticoagulants
Multicenter Studies
Andexanet alfa for the reversal of factor Xa inhibitors
Favresse, J., Hardy, M., van Dievoet, M. A., Sennesael, A. L., Douxfils, J., Samama, C. M., Vornicu, O., Dincq, A. S., Lessire, S. & Mullier, F., 4 May 2019, In : Expert Opinion on Biological Therapy. 19, 5, p. 387-397 11 p.Research output: Contribution to journal › Article
Pharmacodynamics
Hemorrhage
Phase III Clinical Trials
Factor Xa
Pharmacokinetics
Anti-alcohol abuse drug disulfiram inhibits human PHGDH via disruption of its active tetrameric form through a specific cysteine oxidation
Spillier, Q., Vertommen, D., Ravez, S., Marteau, R., Thémans, Q., Corbet, C., Feron, O., Wouters, J. & Frédérick, R., 1 Dec 2019, In : Scientific Reports. 9, 1, 4737.Research output: Contribution to journal › Article
Open Access
Phosphoglycerate Dehydrogenase
Disulfiram
Alcoholism
Cysteine
Pharmaceutical Preparations
Activities 2011 2019
A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes
Jonathan Douxfils (Invited speaker)9 Jul 2019
Activity: Talk or presentation types › Oral presentation
ISTH 2019 : The XXVII Congress of the International Society on Thrombosis and Haemostasis
Jonathan Douxfils (Member of Scientific Committee)6 Jul 2019 → 10 Jul 2019
Activity: Participating in or organising an event types › Participation in conference
Portola Pharmaceuticals
Jonathan Douxfils (Expert)7 Jul 2019
Activity: Consultancy types › Consultancy
Prizes
3rd Runner-up at the "Why Medicinal Chemistry" competition
Charlotte Bouckaert (Recipient), 16 Sep 2015
Prize: Prize (including medals and awards)
56th ASH Annual Meeting and Exposition - Abstract Achievement Award
Jonathan Douxfils (Recipient), 6 Dec 2014
Prize: Prize (including medals and awards)
Bourse de formation doctorale
Charlotte Bouckaert (Recipient), 2014
Prize: Prize (including medals and awards)
Press / Media
Les Éclaireurs: Hématologie, Marionette & Bioluminescence
14/07/18
1 Media contribution
Press/Media: Research
Datasets
CCDC 813565: Experimental Crystal Structure Determination
Frederick, R. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2012
DOI: 10.5517/ccw9l1s, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccw9l1s&sid=DataCite
Dataset
CCDC 794450: Experimental Crystal Structure Determination
Dolusic, E. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2011
DOI: 10.5517/ccvnpfl, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccvnpfl&sid=DataCite
Dataset
CCDC 794451: Experimental Crystal Structure Determination
Dolusic, E. (Contributor), Cambridge Crystallographic Data Centre, 1 Jan 2011
DOI: 10.5517/ccvnpgm, http://www.ccdc.cam.ac.uk/services/structure_request?id=doi:10.5517/ccvnpgm&sid=DataCite
Dataset
Student theses
Analytical and clinical validation of sensitive assays for the diagnosis of immune heparin-induced thrombocytopenia
Author: Minet, V., 2017Supervisor: Dogne, J. (Supervisor), Mullier, F. (External person) (Co-Supervisor), Laloy, J. (Jury), Lucas, S. (Jury), Masereel, B. (Jury), Chatelain, M. (External person) (Jury), Hoylaerts, M. F. (External person) (Jury) & Tardy, B. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Design, synthesis and evaluation of coagulation FXIIa inhibitors as potential antithrombotic agents
Author: Bouckaert, C., 16 May 2017Supervisor: Pochet, L. (Supervisor), Dogne, J. (Co-Supervisor), Lanners, S. (President), De Tullio, P. (External person) (Jury), Chatelain, C. (External person) (Jury) & TEN CATE, H. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences
Evaluation of thrombotic and/or bleeding risks associated with anticoagulotherapy.
Author: Douxfils, J., 24 Oct 2015Supervisor: Dogne, J. (Supervisor), Mullier, F. (Supervisor), Masereel, B. (President), Chatelain, B. (Jury), Chatelain, C. (External person) (Jury), Verhamme, P. (External person) (Jury), TEN CATE, H. (External person) (Jury) & Ageno, W. (External person) (Jury)
Student thesis: Doc types › Doctor of Biomedical and Pharmaceutical Sciences